TREATMENT OF MELANOMA BY PASSIVE HUMORAL IMMUNOTHERAPY USING ANTIBODY DRUG SYNERGISM
- 21 May 1977
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 309 (8021), 1105-1106
- https://doi.org/10.1016/s0140-6736(77)92359-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis.Gut, 1976
- Suppression of tumour growth in mice by a drug–antibody conjugate using a novel approach to linkageNature, 1975
- Immunochemotherapy of human malignant melanoma with chlorambucil-carrying antibodyEuropean Journal of Cancer (1965), 1975
- Comparison of the combination of 1, 3-bis(2-chloroethyl)-l-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-l-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanomaCancer, 1975
- Protection of Mice Against Syngeneic LymphomataBritish Journal of Cancer, 1974
- Protection of Mice Against Syngeneic LymphomataBritish Journal of Cancer, 1974
- Immunochemotherapy of Cancer with Chlorambucil-carrying AntibodyBMJ, 1972
- Antibody as carrier of chlorambucilCancer, 1972